Edition:
United Kingdom

Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

3.21USD
8:59pm GMT
Change (% chg)

$-0.09 (-2.73%)
Prev Close
$3.30
Open
$3.25
Day's High
$3.29
Day's Low
$3.19
Volume
26,428
Avg. Vol
33,823
52-wk High
$5.00
52-wk Low
$2.35

Chart for

About

Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $175.64
Shares Outstanding(Mil.): 51.13
Dividend: --
Yield (%): --

Financials

  CGEN.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.67 -- --
ROI: -52.36 0.28 15.02
ROE: -54.94 0.94 16.60

Bristol-Myers to invest in Compugen, collaborate in clinical trials

TEL AVIV Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.

11 Oct 2018

Bristol-Myers to invest in Compugen, collaborate in clinical trials

TEL AVIV, Oct 11 Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumours.

11 Oct 2018

Earnings vs. Estimates